|
FRACTION OF EXHALED NITRIC OXIDE (FENO) AND INTERFERRAL FACTORS |
|
INCREASED FeNO | DECREASED FeNO | STUDIES |
Drug intake: | Drug intake: | Sumino H, et al [35], Holden WE, et al [36], Runer T, et al [37], Sippel JM, et al [38], Yates DH, et al [39] |
(i) ACE inhibitors [35]; | (i) Oxymetazoline [38]; |
(ii) Papaverin [36]; | (ii) NOS inhibitors [39]; |
(iii) Sodium nitroprusside [37]. | |
Food and Beverages: | Food and Beverages: | McKnight GM, et al [40], Tenero L, et al [41] |
(i) Nitrite/Nitrate-enriched food [40]; | (i) Curcumin and Resveratrol [41] |
(ii) Arginine ingestion [40]. | |
Environmental factors: | Environmental factors: | Binding N, et al [42], Franklin P, et al. [43], Nightingale JA, et al [44] |
(i) NO in air [42]; | (i) Calibration of FeNO analyser [42]; |
(ii) Calibration of FeNO analyser [43]; | |
(iii) Occupational exposure to ozone, chlorine dioxide, formaldehyde [44]; | |
Physiological and pathological conditions and tests: | Physiological and pathological conditions and tests: | Kharitonov SA, et al [45], Liu PF, et al [46], Chen FJ, et al [47], Uppalapati A, et al [48], Song WJ, et al [49], Xu X, et al [50], Yates DH, et al [51], Dimov PK, et al [52], Deykin A, et al [53], Piacentini A, et al [54], Pendergast DR, et al [55], Phillips CR, et al [56], Kharitonov SA, et al [57], Tang S, et al [58], Murri V, et al [59] |
(i) Airway Infections [45]; | (i) Tabagism [50]; |
(ii) Lung neoplasia [46]; | (ii) Alcohol ingestion [51]; |
(iii) COPD [47]; | (iii) Chronic hypoxia [52]; |
(iv) Asthma [47]; | (iv) Spirometry [53]; |
(v) Systemic inflammatory conditions [48]; | (v) Sputum induction [54]; |
(vi) Chronic cough [49]. | (vi) Hypothermia [55]; |
| (vii) Hyperventilation [53]; |
| (viii) Physical exercise [56]; |
| (ix) Menstrual cycle [57]; |
| (x) Childhood [58]; |
| (xi) Female gender [59]. |
Sickle anemia [60], circadian rhythm [61], and pregnancy [62] are actually under consideration | Cohen RT, et al [60], Saito J, et al [61], Nittner-Marszalska M, et al [62] |
|